StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Monday. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
CALA stock opened at $0.03 on Monday. Calithera Biosciences has a twelve month low of $0.01 and a twelve month high of $0.50. The company’s 50 day moving average is $0.02 and its two-hundred day moving average is $0.03.
Calithera Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Calithera Biosciences
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Overbought Stocks Explained: Should You Trade Them?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
